Jiangsu Kanion Pharmaceutical Co.,Ltd.’s Net Profit Rose 8.6% in First Half of 2021

Jiangsu Kanion Pharmaceutical Co.,Ltd. (江苏康缘药业股份有限公司) (600557.SH) reported a net profit of 161.6 million yuan in the first half of 2021, up 8.6% year-on-year.

Meanwhile, the company posted 1.8 billion yuan in revenue, up 14.3% year-on-year.

At the end of the reporting period, it had 5.8 billion yuan in total assets and 1.5 billion yuan in total liabilities, with a liability-to-asset ratio of 25.4%.

This article was automatically produced by Caixin Automation on Aug. 26, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.